M SILDENAFIL (is an active metabolite) | SILDENAFIL | ATC G04BE03
GENITO ERECTILE DYSFUNCTION (THERAPEUTIC) SPECIFIC PHOSPHODIESTERASE INHIBITORS VASODILATOR AGENTS THE METABOLITE ACCOUNTS FOR ABOUT 20 PERCENT OF SILDENAFIL PHARMACOLOGIC TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) (DRUG FOR RARE DISEASE IN EUROPE) | - | | PHOSPHODIESTERASE TYPE 5 (PDE5) | PHOSPHODIESTERASE 5A INHIBITOR CHEMBL1827 PHOSPHODIESTERASE 5A O76074 CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE HOMO SAPIENS ENZYME PHOSPHODIESTERASE PDE_5 PDE_5A | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |